Inhibition of ribonucleotide reductase by α-(N)-heterocyclic carboxaldehyde thiosemicarbazones
- 31 December 1984
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 24 (3) , 439-447
- https://doi.org/10.1016/0163-7258(84)90013-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- Effect of iron-chelating agents on inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1981
- Combined modality of 2-formylpyridine monothiosemicarbazonato copper(II) and radiationInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Potentiation of the antitumour activity of 2-formylpyridine thiosemicarbazone by metal chelation: 2-formylpyridine thiosemicarbazone zinc sulphate (NSC 294721)Published by Elsevier ,1979
- Elucidation of the structure of the antineoplastic agents, 2-formylpyridine and 1-formylisoquinoline thiosemicarbazonesJournal of Medicinal Chemistry, 1977
- Potential antitumor agents. 13. 4-Methyl-5-amino-1-formylisoquinoline thiosemicarbazoneJournal of Medicinal Chemistry, 1976
- Inhibition of tumor cell transplantability by iron and copper complexes of 5-substituted 2-formylpyridine thiosemicarbazonesJournal of Medicinal Chemistry, 1976
- .alpha.-(N)-Formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activityJournal of Medicinal Chemistry, 1974
- Ribonucleotide Reductase and Cell ProliferationJournal of Biological Chemistry, 1970
- The Carcinostatic Activity of Thiosemicarbazones of Formyl Heteroaromatic Compounds.1 III. Primary CorrelationJournal of Medicinal Chemistry, 1966